Filing Details

Accession Number:
0001765581-22-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-03 16:37:58
Reporting Period:
2022-03-01
Accepted Time:
2022-03-03 16:37:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193210 C Bruce Cozadd 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-03-01 9,700 $46.83 335,488 No 4 M Direct
Ordinary Shares Disposition 2022-03-01 3,260 $135.73 332,228 No 4 S Direct
Ordinary Shares Disposition 2022-03-01 3,041 $136.73 329,187 No 4 S Direct
Ordinary Shares Disposition 2022-03-01 200 $137.40 328,987 No 4 S Direct
Ordinary Shares Disposition 2022-03-02 6,000 $150.00 322,987 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2022-03-01 9,700 $0.00 9,700 $46.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,432 2022-08-08 No 4 M Direct
Footnotes
  1. Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.18 to $136.12. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $136.18 to $137.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.255 to $137.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  5. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  6. This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.